| mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |